Canada markets closed

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.49+0.07 (+0.33%)
At close: 04:00PM EDT
21.49 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.82B
Enterprise Value 1.64B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)681.28
Price/Book (mrq)8.19
Enterprise Value/Revenue 792.57
Enterprise Value/EBITDA -18.71

Trading Information

Stock Price History

Beta (5Y Monthly) -0.72
52-Week Change 3410.00%
S&P500 52-Week Change 321.33%
52 Week High 321.58
52 Week Low 32.31
50-Day Moving Average 317.40
200-Day Moving Average 38.43

Share Statistics

Avg Vol (3 month) 32.1M
Avg Vol (10 day) 3560.1k
Shares Outstanding 584.86M
Implied Shares Outstanding 684.86M
Float 863.17M
% Held by Insiders 10.47%
% Held by Institutions 179.14%
Shares Short (Apr 15, 2024) 44.86M
Short Ratio (Apr 15, 2024) 41.12
Short % of Float (Apr 15, 2024) 46.73%
Short % of Shares Outstanding (Apr 15, 2024) 45.73%
Shares Short (prior month Mar 15, 2024) 47.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,798.45%

Management Effectiveness

Return on Assets (ttm)-24.57%
Return on Equity (ttm)-49.33%

Income Statement

Revenue (ttm)2.07M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -97.89M
Net Income Avi to Common (ttm)-94.9M
Diluted EPS (ttm)-1.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)233.61M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)50.33M
Total Debt/Equity (mrq)22.62%
Current Ratio (mrq)15.01
Book Value Per Share (mrq)2.79

Cash Flow Statement

Operating Cash Flow (ttm)-81.8M
Levered Free Cash Flow (ttm)-58.58M